相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protective Effects of GLP-1 on Glomerular Endothelium and Its Inhibition by PKCβ Activation in Diabetes
Akira Mima et al.
DIABETES (2012)
Glomerular VEGF resistance induced by PKCβ/SHP-1 activation and contribution to diabetic nephropathy
Akira Mima et al.
FASEB JOURNAL (2012)
Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats
Wei Jing Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria: Ten years of follow-up of Prevention of Renal and Vascular End-stage Disease Intervention Trial (PREVEND IT)
Frank P. Brouwers et al.
AMERICAN HEART JOURNAL (2011)
Attenuation of Glomerular Injury in Diabetic Mice with Tert-Butylhydroquinone through Nuclear Factor Erythroid 2-Related Factor 2-Dependent Antioxidant Gene Activation
Hang Li et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b-4 CKD
Pablo E. Pergola et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling
P. Palsamy et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
Hongting Zheng et al.
DIABETES (2011)
Adiponectin reduces proteinuria in streptozotocin-induced diabetic Wistar rats
Shintaro Nakamaki et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Glomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity
Akira Mima et al.
KIDNEY INTERNATIONAL (2011)
Inhibition of inflammation by pentosan polysulfate impedes the development and progression of severe diabetic nephropathy in aging C57B6 mice
Jin Wu et al.
LABORATORY INVESTIGATION (2011)
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
NATURE REVIEWS NEPHROLOGY (2011)
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pablo E. Pergola et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Loss of Insulin Signaling in Vascular Endothelial Cells Accelerates Atherosclerosis in Apolipoprotein E Null Mice
Christian Rask-Madsen et al.
CELL METABOLISM (2010)
Combination of aspirin with telmisartan suppresses the augmented TGFβ/smad signaling during the development of streptozotocin-induced type I diabetic nephropathy
Shrikant Ramesh Mulay et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy
Chia-Chao Wu et al.
CLINICA CHIMICA ACTA (2010)
Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor
O. Erdogdu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Local Delivery of Angiotensin II Receptor Blockers into the Kidney Passively Attenuates Inflammatory Reactions during the Early Phases of Streptozotocin-Induced Diabetic Nephropathy through Inhibition of Calpain Activity
Fadia Kamal et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2010)
Pathogenic perspectives for the role of inflammation in diabetic nephropathy
Antonio Rivero et al.
CLINICAL SCIENCE (2009)
Effect of the Monocyte Chemoattractant Protein-1/CC Chemokine Receptor 2 System on Nephrin Expression in Streptozotocin-Treated Mice and Human Cultured Podocytes
Elena Tarabra et al.
DIABETES (2009)
Intensive insulin therapy decreases urinary MCP-1 and ICAM-1 excretions in incipient diabetic nephropathy
S. D. Ye et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
The Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease
Wilfred Lieberthal et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity
Satoshi Nishimura et al.
NATURE MEDICINE (2009)
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease
James Shepherd et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats
Gang Jee Ko et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Salsalate Improves Glycemia and Inflammatory Parameters in Obese Young Adults
Amy Fleischman et al.
DIABETES CARE (2008)
A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease
Marvin Sinsakul et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications
Sridevi Devaraj et al.
DIABETES (2007)
Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy
Hiroshi Kanamori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity
P. Newsholme et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis
Charalambos Antoniades et al.
CLINICAL CARDIOLOGY (2007)
Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice
Cheol Whee Park et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Effect of ruboxistaurin on urina transforming growth factor-β in patients with diabetic nephropathy and type 2 diabetes
Richard E. Gilbert et al.
DIABETES CARE (2007)
Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice
F. Y. Chow et al.
DIABETOLOGIA (2007)
The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology
Karen Bedard et al.
PHYSIOLOGICAL REVIEWS (2007)
Rapamycin prevents early steps of the development of diabetic nephropathy in rats
Yi Yang et al.
AMERICAN JOURNAL OF NEPHROLOGY (2007)
Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cβ -: Null mice
Yuzuru Ohshiro et al.
DIABETES (2006)
Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone
Hisashi Makino et al.
DIABETES (2006)
RAGE control of diabetic nephropathy in a mouse model -: Effects of RAGE gene disruption and administration of low-molecular weight heparin
Khin-Mar Myint et al.
DIABETES (2006)
Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress
Stefano Menini et al.
DIABETES (2006)
NADPH oxidases in cardiovascular health and disease
Alison C. Cave et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice
M Sakaguchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Leukocyte recruitment and vascular injury in diabetic nephropathy
Elena Galkina et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice
FY Chow et al.
KIDNEY INTERNATIONAL (2006)
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
DM Nathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy
K Nagai et al.
KIDNEY INTERNATIONAL (2005)
Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade:: A short-term, randomized, controlled trial
JF Navarro et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner
Y Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
An overview on biological mechanisms of PPARs
BP Kota et al.
PHARMACOLOGICAL RESEARCH (2005)
Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury
F Chow et al.
KIDNEY INTERNATIONAL (2004)
Attenuation of mouse mesangial cell contractility by high glucose and mannitol: Involvement of protein kinase C and focal adhesion kinase
JS Chen et al.
JOURNAL OF BIOMEDICAL SCIENCE (2004)
Hyperglycemia-induced oxidative stress in diabetic complications
GL King et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2004)
Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes
S Okada et al.
DIABETES (2003)
Translocation of glomerular p47phox and p67phox by protein kinase C-β activation is required for oxidative stress in diabetic nephropathy
M Kitada et al.
DIABETES (2003)
Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus
JF Navarro et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance
D Vicent et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Elevated levels of interleukin-18 and tumor necrosis factor-α in serum of patients with type 2 diabetes mellitus:: Relationship with diabetic nephropathy
Y Moriwaki et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
Combination of pentoxifylline with angiotensin converting enzyme inhibitors produces an additional reduction in microalbuminuria in hypertensive type 2 diabetic patients
O Harmankaya et al.
RENAL FAILURE (2003)
Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension
HF Cheng et al.
KIDNEY INTERNATIONAL (2002)
Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats
M Kakimoto et al.
DIABETES (2002)
Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients
P Gæde et al.
DIABETIC MEDICINE (2001)
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ
MS Yuan et al.
SCIENCE (2001)
Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser1179
M Montagnani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease
YF Guan et al.
KIDNEY INTERNATIONAL (2001)
Insulin inhibits NF kappa B and MCP-1 expression in human aortic endothelial cells
A Aljada et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells
ZQ Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm
A Mezzetti et al.
CARDIOVASCULAR RESEARCH (2000)
Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy
N Banba et al.
KIDNEY INTERNATIONAL (2000)
Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo A specific vascular action of insulin
K Kuboki et al.
CIRCULATION (2000)
Vitamin E supplementation and cardiovascular events in high-risk patients
S Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats
C Sassy-Prigent et al.
DIABETES (2000)
分享论文
